EUVIMEDEUVIMED entdecken
Open Access

Integration of Consolidation Chemotherapy After Concurrent Chemoradiation in the Treatment of Locally Advanced Uterine Cervical Cancer

V S Haritha iD, Laxmi Singotia iD, Rajesh Jain iD, A K Saxena, Shyamji Rawat iD, Lalit Patel iD

Indian Journal of Gynecologic Oncology · 2022-12 · 20 (4)

DOI: 10.1007/s40944-022-00646-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Gynecologic Oncology, online erschienen am 19.11.2022. Verfasst von V S Haritha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Netaji Subhash Chandra Bose Medical College, Jabalpur, Madhya Pradesh India. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite the current standard of concurrent chemoradiation (CCRT), around 30-40% are still dying from locally advanced cervical cancer. Increasing the radiation dose further was not a feasible option, but addition of chemotherapy further was tried due to the different toxicity profiles of it. So, the use of consolidation chemotherapy beyond CCRT has been studied.

Aim

To evaluate the efficacy, toxicity, tumour response and loco-regional control following consolidation chemotherapy after concurrent chemoradiation in locally advanced carcinoma cervix (LACC).

Methods

The patients were randomized into two arms: the conventional arm (control arm, n = 30) patients received conventional treatment with weekly injection cisplatin (35 mg/m2) concurrently with pelvic external beam radiation (50 Gy/25 fraction, 2 Gy/fraction, 5 fraction weekly) followed by intracavitary radiotherapy of 21 Gy in 3 fractions of 7 Gy each by HDR brachytherapy. In the interventional arm (study arm, n = 30), patients received the standard treatment followed by 3 cycles of consolidation chemotherapy (paclitaxel + carboplatin) every three weekly.

Results

Haematological toxicity (grade 3 anaemia and grade 1 leucopenia, grade 1 and 2 thrombocytopenia) was higher in the study group. Renal, hepatic and gastrointestinal toxicity was more in the study arm. Peripheral neuropathy was mostly seen in the study arm. Median follow-up was 9 months. Treatment response was better, and the rate of recurrence was less in the study arm.

Conclusion

Addition of few cycles of consolidation chemotherapy after standard treatment is beneficial in patients with LACC with manageable toxicity and good compliance.

Schlagwörter

Stichwörter der Autor:innen

Cervical cancerConcurrent chemoradiationConsolidation chemotherapyLACC

Autor:innen und Institutionen

  • Department of Radiation Oncology, Netaji Subhash Chandra Bose Medical College, Jabalpur, Madhya Pradesh India.

ORCID-Profile: V S Haritha, Laxmi Singotia, Rajesh Jain, Shyamji Rawat, Lalit Patel

Zitieren

APA

Haritha, V. S., Singotia, L., Jain, R., Saxena, A. K., Rawat, S., & Patel, L. (2022). Integration of Consolidation Chemotherapy After Concurrent Chemoradiation in the Treatment of Locally Advanced Uterine Cervical Cancer. Indian Journal of Gynecologic Oncology, 20(4). https://doi.org/10.1007/s40944-022-00646-9

Vancouver

Haritha VS, Singotia L, Jain R, Saxena AK, Rawat S, Patel L. Integration of Consolidation Chemotherapy After Concurrent Chemoradiation in the Treatment of Locally Advanced Uterine Cervical Cancer. Indian Journal of Gynecologic Oncology. 2022;20(4). doi:10.1007/s40944-022-00646-9

BibTeX
@article{Haritha2022,
  author = {Haritha, V S and Singotia, Laxmi and Jain, Rajesh and Saxena, A K and Rawat, Shyamji and Patel, Lalit},
  title = {Integration of Consolidation Chemotherapy After Concurrent Chemoradiation in the Treatment of Locally Advanced Uterine Cervical Cancer},
  journal = {Indian Journal of Gynecologic Oncology},
  year = {2022},
  volume = {20},
  number = {4},
  doi = {10.1007/s40944-022-00646-9}
}
Kostenlos starten →